Predictive analytics is transforming clinical trial operations, from enrollment forecasting to risk-based monitoring. Here’s what sponsors need to know.
- RWE Is Ready — Decision Making For Pharmaceuticals Isn't
- Building A Future-Proof, GxP-Compliant IT Infrastructure
- Unlocking Biopharma Innovation With Real-World Evidence
- AI And Clinical Trial Recruitment: Can It Fix The Funnel?
- Elsa's AI Model Migration: Technical, Compliance, And Regulatory Risks For Sponsors (Part 2)
- From Real-World Data To Real-World Impact: Building The Evidence Capability Pharma Actually Needs
- A Clinical Machine Learning Operations (MLOps) Maturity Framework For Biopharma
- Making AI Work For Clinical Trial Supply
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Using eConsent Data To Populate Site And Sponsor Data Systems
A top-10 pharmaceutical company was looking to reduce the amount of administrative burden on their clinical trial sites and themselves. See how we accomplished it, using eConsent.
-
From Frustration To Organization: An SSO Platform For Trial Sites
To reap the benefits of tech innovation, sponsors and sites need a single sign-on (SSO) solution that enables streamlined organization across different trials and clinical systems.
-
What Does EDC Look Like In 2024 And Beyond?
Read along as industry experts from TrialKit offer insights into the anticipated developments and challenges surrounding electronic data capture.
-
Accelerating Your New Therapies Path To Market With Automation
Automation has become an essential tool for addressing the inefficiencies in traditional clinical trial methodologies, enabling trial teams to instead concentrate on critical tasks such as patient care.
-
A Data-Driven Approach To Clinical Trial Site Selection
By incorporating data-driven site selection and verification, sponsors can optimize resource allocation, enhance protocol compliance, and improve overall trial integrity.
-
Navigating eCOA Licensing And Localization In Clinical Trials
eCOA has been key in trials for 20 years, but issues like licensing, localization, and execution quality still challenge sponsors.
-
Commercializing Rare Disease Treatment With Near Real-Time Alerts
How did Quest help a leading pharmaceutical company overcome the data latency challenges associated with traditional EHR when recruiting eligible patients for a rare blood disorder drug?
-
Mitigating Study Risk With Performance Analytics
Performance metrics for supporting risk-based management can be great, however, this author tells readers why collecting and analyzing data after a study has begun may not be the best approach.
-
Beyond The Pandemic: Why eCOAs Are Here To Stay
The permanent adoption of eCOA is a natural step in the industry-wide effort to create a more patient-centric clinical trial experience. Learn more in the available blog.
-
Introducing Digitally-Enabled Biosample Consent Storage
Despite the rise of digital solutions in healthcare, paper consent forms are still common in today’s clinical trials. Unfortunately, these paper forms pose significant challenges in retaining the documentation of informed consent for centrally stored biospecimens.
RECENT NEWSLETTERS
- 04.04.26 -- Your March Briefing: The Best In Clinical Trial Tech
- 04.02.26 -- AI Is Reshaping Clinical Trials: Here's How to Keep Up
- 03.26.26 -- AI, Telehealth & The Tools Reshaping Clinical Trials
- 03.19.26 -- Clinical Trials In 2026: AI, Telehealth & The Platform Shift
- 03.12.26 -- The Future Of Clinical Trials Is Being Built Right Now